Gilead Sciences’s Merus MRUS Stock Holding History

Gilead Sciences’s Portfolio MRUS Stock Details MRUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-452,527	Closed	-$42.6M	–	8
2025 Q3	$42.6M	Hold	452,527	–	–	2.38%	5
2025 Q2	$23.8M	Hold	452,527	–	–	1.86%	6
2025 Q1	$19M	Hold	452,527	–	–	1.61%	5
2024 Q4	$19M	Buy	+452,527	New	+$21.7M	1.23%	5

Other funds holding MRUS

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gilead Sciences's MRUS Position: Q4 2025 in Review

Gilead Sciences sold out of Merus (MRUS) in Q4 2025, closing a stake of 452,527 shares — an estimated $42.6M sold.

Gilead Sciences first reported a position in MRUS in Q4 2024 and held it in 4 quarters. The position peaked at $42.6M in Q3 2025. 10 funds tracked by Wall St. Rank hold MRUS as of Q4 2025.

Gilead Sciences reported no remaining Merus position as of Q4 2025 after selling out during the quarter.
Gilead Sciences sold 452,527 Merus shares in Q4 2025, an estimated $42.6M.
Gilead Sciences first reported a position in Merus in Q4 2024 and held it in 4 quarters.
Gilead Sciences's Merus position peaked at $42.6M in Q3 2025.
10 funds tracked by Wall St. Rank held Merus as of Q4 2025.

Based on Gilead Sciences's 13F filing for Q4 2025, filed 12 Feb 2026.